PentaBase, headquartered in Odense (Dänemark), offers a comprehensive range of products for molecular diagnostics and genetic testing with a focus on cancer markers and hematological diseases. The products are based on proprietary INA® technology, which enables improved sensitivity, specificity, and efficiency.
Supplier homepage: https://pentabase.com/
Fast results in less than 2 hours
Compatible with standard real-time PCR devices (open platform design)
Product Portfolio
SensiScreen®
qPCR Assays:
Highly sensitive detection of somatic mutations in FFPE tumor tissue and cell-free DNA (cfDNA) for liquid biopsy.
Solid Tumors:
- BRAF (V600E)
- EGFR (various mutations relevant for lung cancer)
- KRAS (various exons)
- NRAS (Exon 3)
- PIK3CA (only in Liquid variant)
Hematology:
- MYD88 (L265P)
- KIT D816V (Mastocytosis)
EpiDirect®
Methylation Analysis:
- Direct analysis of DNA methylation status without bisulfite conversion
-
MGMT promoter methylation in glioblastomas
-
MLH1 methylation for the diagnosis of Lynch syndrome
MicroSight®
MSI:
Analysis of microsatellite instability (MSI)
-
Parameters: BAT25, BAT26, NR22, and MONO27 microsatellites
Webinar:
SensiScreen - A Simple Guide to Precision Diagnostics
We will introduce how SensiScreen can improve diagnostics, stratification, and monitoring of cancer disease. We’ll explore:
- Liquid Biopsy Focus – How it helps detect disease activity earlier
- Clinical Impact – Reducing unnecessary steps and improving patient care
- Real-World Data – Insights from the latest PIK3CA liquid biopsy publication
- Custom & Hotspot Mutation Assays – Flexible solutions for various clinical needs
This session is designed for lab technicians, clinicians, and decision-makers looking for practical and effective molecular diagnostic solutions.
We support you in establishing individual workflows and provide personal consultation on product specifications and areas of application.
